ONCOLYTICS BIOTECH INC (ONC.CA) Stock Analyst Earnings Estimates
TSX:ONC - Toronto Stock Exchange - CA6823108759 - Common Stock - Currency: CAD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A 2,070.87% | N/A 520.58% | N/A 170.47% | N/A 32.77% | N/A -9.49% | N/A 44.15% | ||||||||||||
| EBITDA YoY % growth | -18.43M | -14.32M 22.30% | -14.96M -4.47% | -15.59M -4.21% | -17.17M -10.13% | -19.88M -15.78% | -25.01M -25.80% | -25.78M -3.08% | -26.53M -2.91% | -33.388M -25.85% | -34.558M -3.50% | N/A -81.49% | N/A -42.03% | N/A 64.74% | N/A 324.04% | N/A 121.68% | N/A 51.62% | N/A -34.27% | N/A 46.58% | |
| EBIT YoY % growth | -18.59M | -14.5M 22.00% | -15.12M -4.28% | -15.68M -3.70% | -17.27M -10.14% | -20.37M -17.95% | -25.46M -24.99% | -26.23M -3.02% | -26.92M -2.63% | -33.791M -25.52% | -34.982M -3.52% | N/A -22.07% | N/A -31.21% | N/A 28.43% | N/A 316.53% | N/A 148.76% | N/A 46.64% | N/A 18.37% | N/A 49.34% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -1.90 | -1.14 40.00% | N/A -13.62% | -1.14 11.99% | -1.04 9.21% | -0.93 10.14% | -0.43 53.76% | -0.49 -13.95% | -0.44 10.20% | -0.41 6.82% | -0.41 | N/A 1.46% | N/A -4.37% | N/A 20.16% | N/A 62.89% | N/A 1,068.31% | N/A 106.90% | N/A 51.67% | N/A 43.95% |
All data in CAD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.11 -7.74% | -0.11 10.22% | -0.11 -6.05% |
| Revenue Q2Q % growth | |||
| EBITDA Q2Q % growth | -17.877M -132.20% | -18.584M -94.13% | N/A |
| EBIT Q2Q % growth | -11.125M -40.46% | -11.817M -19.38% | N/A |
All data in CAD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.08 11.11% | -0.10 | 0.02 | 20.79% |
| Q4 2024 Q2Q % growth | -0.10 -100.00% | -0.12 | 0.02 | 18.74% |
| Q3 2024 Q2Q % growth | -0.12 14.29% | -0.10 | -0.02 | -15.35% |
| Q2 2024 Q2Q % growth | -0.10 16.67% | -0.10 | 0.00 | 3.10% |
| Q1 2024 Q2Q % growth | -0.09 10.00% | -0.11 | 0.02 | 17.49% |
| Q4 2023 Q2Q % growth | -0.05 66.67% | -0.15 | 0.10 | 66.41% |
| Q3 2023 Q2Q % growth | -0.14 -75.00% | -0.11 | -0.03 | -33.28% |
| Q2 2023 Q2Q % growth | -0.12 -33.33% | -0.11 | -0.01 | -5.24% |
| Q1 2023 Q2Q % growth | -0.10 16.67% | -0.13 | 0.03 | 25.28% |
| Q4 2022 Q2Q % growth | -0.15 -7.14% | -0.10 | -0.05 | -53.17% |
| Q3 2022 Q2Q % growth | -0.08 11.11% | -0.11 | 0.03 | 27.82% |
| Q2 2022 Q2Q % growth | -0.09 30.77% | -0.11 | 0.02 | 16.46% |
| Q1 2022 Q2Q % growth | -0.12 7.69% | -0.15 | 0.03 | 18.99% |
| Q4 2021 Q2Q % growth | -0.14 36.36% | -0.13 | -0.01 | -9.43% |
| Q3 2021 Q2Q % growth | -0.09 43.75% | -0.14 | 0.05 | 37.83% |
| Q2 2021 Q2Q % growth | -0.13 23.53% | -0.12 | -0.01 | -7.26% |
| Q1 2021 Q2Q % growth | -0.13 -208.33% | -0.18 | 0.05 | 25.74% |
| Q4 2020 Q2Q % growth | -0.22 12.00% | -0.15 | -0.07 | -45.21% |
| Q3 2020 Q2Q % growth | -0.16 -6.67% | -0.14 | -0.02 | -13.15% |
| Q2 2020 Q2Q % growth | -0.17 34.62% | -0.14 | -0.03 | -24.68% |
| Q1 2020 Q2Q % growth | 0.12 144.44% | -0.25 | 0.37 | 147.52% |
| Q4 2019 Q2Q % growth | -0.25 | -0.15 | -0.10 | -65.02% |
| Q3 2019 Q2Q % growth | -0.15 | -0.22 | 0.07 | 32.49% |
| Q2 2019 Q2Q % growth | -0.26 | -0.26 | 0.00 | -0.95% |
| Q1 2019 Q2Q % growth | -0.27 | -0.29 | 0.02 | 7.82% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -18.52% | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |